CME Plans to Sue CFTC Over Perpetual Futures Approval Decision
CME Group's CEO says the exchange intends to take the CFTC to court following a controversial perpetual futures approval.
CME Group's chief executive has made it clear the company isn't taking a recent regulatory decision lying down — the futures and derivatives giant is gearing up to sue the Commodity Futures Trading Commission (CFTC) following the regulator's approval of perpetual futures contracts.
Perpetual futures, if you're not deep in the trading weeds, are a type of derivative contract popular in crypto markets that never actually expire. Unlike traditional futures, which have a set settlement date, perpetuals let traders hold positions indefinitely, which has made them wildly popular on offshore crypto exchanges. The CFTC's decision to give them the green light in the US market has clearly rattled CME, one of the world's largest and most established derivatives exchanges.
Read more Dimensional Fund Advisors Discloses Stake in Gamma Communications →
CME's CEO apparently believes the regulatory approval was improper, setting the stage for what could become a significant legal battle between a major market institution and its own federal regulator. It's a rare move — established financial players don't typically haul regulators into court — and it signals just how seriously CME views the competitive threat posed by perpetual futures entering regulated US markets.
The clash also highlights a broader tension in derivatives markets right now: legacy exchanges built on traditional contract structures are watching crypto-native products inch their way into mainstream regulatory acceptance, and not everyone is happy about how that process is unfolding. Whether CME's legal challenge succeeds or not, the lawsuit is likely to spotlight questions about how the CFTC weighs innovation against market fairness when approving new products.
Continue reading at CoinDesk.
